Physician profile
Timothy B Griffith
NPI 1588820278
$3,699.17
in general payments reported to CMS, 2019-2025
13 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $1,380 · 2021: $71.98 · 2022: $296 · 2023: $824 · 2024: $693 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,058 · Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,058.24 |
| Food and Beverage | $673.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Orthopedics LLC | $2,067.15 | 2020-2024 | |
| Arthrex, INC. | $762.80 | 2022-2024 | |
| Horizon Therapeutics Plc | $256.07 | 2019-2021 | |
| Arteriocyte Medical Systems, INC. | $146.42 | 2024 | Magellan |
| Innovation Technologies INC | $121.78 | 2025 | Irrisept |
| Avanos Medical | $99.87 | 2022 | |
| Ermi LLC | $71.48 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $52.55 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $34.95 | 2025 | |
| Bioventus LLC | $30.48 | 2024 | Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $22.33 | 2024 | Intracept |
| Inspire Medical Systems, INC. | $18.54 | 2025 | Inspire |
| Smith+Nephew, INC. | $14.75 | 2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.